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ABSTRACT  
Background: The  aim of the present study was  to  determinate  the  possible  
relationship between serum  leptin and lipid peroxidation in male  and female type  2  
diabetic patients in Gorgan, Iran.   
Methods:  The  subjects consisted  of fifty type 2 diabetic patients and  fifty  age and  
sex­matched control  subjects.  The concentration  of leptin, malondialdehyde, lipid  
parameters and  insulin  were measured  in all  subjects. The  results  were  evaluated  
by  using  Independent sample ‘t’ test  and Spearman’s correlation coefficient  test.   
Results: Leptin was  correlated with BMI (male:  r=0.339 and female:  r=0.426,  
p<0.05)  and malondialdehyde  levels  (male: r=0.124  and female: r=0.271,  p<0.05) in  
the type­2  diabetic patients. In the  control subjects,  only a  correlation  between  
leptin and BMI was found  (male:  r=0.165, female:  r= 0.037,  p<0.05).  
Conclusions: In the  correlation  analysis using  leptin as  the dependent variable,  
BMI was found to be  the  predictor of  leptin  in  males and females. Increased lipid  
peroxidation and  hyperleptinaemia  may play a role in  the beginning  and  
development of  type 2 diabetes  mellitus  in this area.  
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Introduction 
Diabetes is a major public health problem
that is approaching epidemic proportions
globally. This metabolic disease is one of
the most common endocrine disorders
affecting almost 6% of the world’s
population [1]. The prevalence of type 2
Diabetes mellitus (DM) ranges from 1.2%
to 14.6% in Asia, 4.6% to 40% in the
Middle East and 1.3% to 14.5 % in Iran
[2],[3]. Diabetes mellitus is considered to
be one of a rank of free radical diseases. It
causes complications, with increased free
radical formation [4]. The process of lipid
peroxidation is one of the oxidative
conversions of polyunsaturated fatty acids
to products known as malondialdehyde
(MDA). MDA is a highly toxic molecule
and its secondary products such as
thiobarbutiric acid reactive substance
(TBARS), are commonly used to evaluate
lipid peroxidation [5]. A major
development in energy balance regulation
came with the discovery in 1994, of leptin,
the protein product of the ob gene [6].The
functions attributed to leptin are extensive,
including the regulation of food intake and
energy balance through central
hypothalamic pathways, its role as a major
signal to the reproductive system in
theinhibition of insulin secretion by
pancreatic-cells and in the stimulation of
glucose transport [7]. Previous studies of
leptin in type 2 diabetes have shown no
difference in basal levels, apart from
expected differences due to BMI [8],[9) or
a reduced leptin level, which may be
Journal of Clinical and Diagnostic Research. 2009 Dec ;(3):xx 
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explained by differences in fat distribution
[10]. Importantly however, the
relationship between leptin and variables
involved in glucose homeostasis and
diabetes might show ethnic differences. A
recent population study of Peruvian
Indians compared with a Caucasian
population showed that the Indians had
higher insulin and lower leptin levels than
the Caucasians [11]. Similarly, Chilean
Indians also had higher insulin and lower
leptin levels than the Caucasians [12].
Furthermore, Mexican American subjects
showed higher levels of leptin as
compared to age and sex-matched non-
Hispanic whites [13]. These results
observed in different ethnic groups
reinforce that studies have to be
undertaken in different populations. Thus,
the aim of the present study was to
investigate the possible relationship
between serum leptin and the lipid
peroxidation of male and female patients
diagnosed with type 2 diabetes mellitus in
Gorgan,Iran.
Materials And Methods 
This study was performed in the
Biochemistry and Metabolic Disorder
Research Center of Gorgan, Iran, in 2008.
We had a study group including 50
patients of type-2 diabetes mellitus who
referred to the Department of Diabetes
Center in 5th Azar Hospital in Golestan
University of Medical Sciences and 50 age
and sex matched healthy control subjects.
At the point of entry into the study, all
diabetic patients underwent clinical and
biochemical investigations. The data were
collected by trained interviewers. The
exclusion criterion was the coexistence of
any other serious illness. Type-2 diabetes
mellitus was defined as nonketosis
diabetes by medical history and it is
currently treated with oral agents. None of
the patients had micro vascular
complications (diabetic nephropathy or
retinopathy). Administration of insulin for
glycaemic control was considered to be an
exclusion criterion. In the controls,
diabetes was excluded by the fasting blood
glucose test. Ten ml of fasting blood was
collected from each subject by
veinpuncture. The samples were
centrifuged for 10 minutes at 3000rpm.
The serum was used for the analyses of
malondialdehyde [14], fasting blood sugar
[15], lipid profile (total cholesterol [16]
including the analysis of triglycerides [17],
HDL-cholesterol [18] VLDL-cholesterol
and LDL cholesterol [19] in those who had
type-2 diabetes mellitus and in controls.
Lipids levels were measured by
biochemical kits and Lipid peroxidation
(the level of lipid peroxidation expressed
as malondialdehyde [MDA]) was
determined using previously described
methods and spectrophotometry
techniques (Model JENWAY 6105 UV /
VIS ) in the Biochemistry and Metabolic
Disorder Research Center (Faculty of
Medicine). The results were reported as
mean± SD. The statistical analysis was
done with SPSS version -11.5 software.
The results were evaluated by using
Independent sample ‘t’ test and
Spearman’s correlation coefficient test. P
values < 0.05 were considered to be
statistically significant.
The Measurement Of Serum 
Leptin 
Serum leptin levels were measured using a
human leptin ELISA test kit (Biovendor,
Research and Diagnostic Products, Czech).
The Measurement Of Serum 
Insulin 
Serum insulin levels were measured
using a human insulin ELISA test kit
(DiaPlus, Immunoenzymometric assay,
USA).
The Measurement Of Serum 
Malondialdehyde 
2.5 ml of trichloroacetic acid was added to
0.5 ml serum and the tube was left to stand
for 10 min at room temperature. After
centrifugation at 3500 rev. / min for 10
min, the supernatant was decanted and the
precipitate was washed once with sulfuric
acid. Then, 2.5 ml of sulfuric acid and 3
ml of thiobarbituric acid (TBA) in sodium
sulfate were added to this precipitate and
the coupling of lipid peroxide with TBA
was carried out by heating this mixture in
a boiling water bath for 30 min. After
cooling in cold water, the resulting
Journal of Clinical and Diagnostic Research. 2009 Dec ;(3):xx 
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chromogen was extracted with 4 ml of n-
butyl alcohol by vigorous shaking.
Separation of the organic phase was
facilitated by centrifugation at 3000
rev./min for 10 min and its absorbance
was determined at awavelength of 530 nm. 
Results 
The clinical characteristics of the type-2
diabetic patients and control subjects are
described in [Table/Fig 1]. The mean
duration of diabetes mellitus in type-2
diabetes mellitus patients was 1.5 years
(range 1-3 years). The mean age of male
and female patients in the type-2 diabetic
and control subjects were 50.38±10.78 (18
males) and 50.46±9.53 (32 females), and
48.40± 10.49 years (20 females) and
48.46± 10.65 years (30 females),
respectively. A number of obvious
differences were found between the two
subjects. The female type 2 diabetes
mellitus patients had higher levels of
fasting blood sugar, total cholesterol,
LDL-cholesterol, HDL-cholesterol,
VLDL-cholesterol, triglycerides,
malondialdehyde, leptin and insulin as
compared to the male subjects. Notably,
the BMI (32.88±5.82 kg/m²),
malondialdehyde (2.57±1.38 nmol/ml) and
leptin levels (34.99±10.19 ng/ml) were
significantly higher in female type-2
diabetes mellitus patients than in diabetic
male subjects (25.05±1.85 kg/m²,
2.10±0.67 nmol/ml and 11.04±7.76
ng/ml,) (P< 0.05) [Table/Fig 1]. The data
shown in Table 1 reveals that the BMI
(30.60±5.50 kg/m²) and leptin levels
(26.34±12.02 ng/ml) was significantly
higher in female control subjects than in
male subjects (25.97±4.36 kg/m² and
11.26±5.46 ng/ml,) (P< 0.05). There was
no significant difference in other
parameters in female type-2 diabetes
mellitus patients and male subjects. The
data of [Table/Fig 1]shows that the levels
of fasting blood sugar, total cholesterol,
LDL-cholesterol, VLDL-cholesterol,
triglycerides, malondialdehyde and insulin
were significantly higher in male and
female (leptin was also higher) type-2
diabetes mellitus patients than in male and
female controls (P< 0.05). But this is not
the same for HDL-cholesterol, age and
BMI in female type-2 diabetes mellitus
patients[Table/Fig 1]. There were no
significant differences in age, BMI, HDL-
cholesterol and leptin in male type-2
diabetes mellitus patients and in male
control subjects. Leptin correlated
positively and significantly with the BMI
of diabetic and control males (r=0.339and
r=0.165, p<0.05) and females (r=0.426
and r=0.037, p<0.05). Leptin also
correlated positively and significantly with
malondialdehyde (MDA) in the male and
female type-2 diabetes mellitus patients
(r= 0.124, r= 0.271, p<0.05) [Table/Fig 2].
Discussion 
In the present study, we have observed
that the levels of malondialdehyde (MDA),
a lipid peroxidation product and a marker
Journal of Clinical and Diagnostic Research. 2009 Dec ;(3):xx 
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of oxidative stress, is increased
significantly in male as well as in female
diabetic patients [Table/Fig 1]. This
apparently shows that diabetic patients are
exposed to an increased oxidative stress
via lipid peroxidation. Some other
researchers have also reported elevated
lipid peroxidation products in the blood
samples of type 2 diabetic patients
[20],[21]. Several studies have shown that
lipid peroxidation is increased in diabetes,
particularly in type 2 diabetes mellitus
[22],[23],[24]. Jain [25] demonstrated that
hyperglycaemia stimulates the lipid
peroxidation of RBC and Kannan and Jain
[26] later showed that it increases
oxidative stress in cells in vitro. Contrary
to our observations and to that of others,
there are several studies which did not find
increased oxidative stress in type 2
diabetes mellitus patients [27].
In an animal study, Midaoui and
Champlain [28] sufferred the rat from type
2 diabetes mellitus and examined
oxidative stress in the model of rat.
Notably, they observed that
hyperglycaemia alone does not induce
oxidative stress unless it was accompanied
by insulin resistance; thereby, implying
that the involvement of reactive oxygen
species is selectively related to insulin
resistance [29]. 
Our results reveal a significant increase in
the concentration of MDA in type 2
diabetic patients as compared to the
control subjects [Table/Fig 1]. This is in
agreement with the other published reports
[22],[23],[24],[25],[26]. Our results show
that BMI, MDA and leptin are statistically
increased in female diabetic patients as
compared to male subjects [Table/Fig 1].
Many investigators have demonstrated that
leptin has a major relationship with BMI
[30],[31],[32],[33],[34],[35]. In our study,
also, leptin showed a correlation with BMI,
both inmales and females with diabetes
and in control subjects. Leptin showed a
correlation with MDA in both males and
females with diabetes. A clear tendency
towards being obese and overweight was
apparent in female and male diabetic
patients (BMI, 30.07±6.08 and 25.05±1.85
kg/m2) and in control subjects (BMI,
30.60±5.50 and 25.97±4.36 kg/m2). Some
of the type 2 diabetes mellitus patients
suffered from Hyperlipidaemia. Therefore,
our results apparently showed that being
obese and overweight gave rise to
increased oxidative stress in type 2
diabetes mellitus patients. Being obesity
and overweight did not change the
oxidative stress in the control subjects.
Our study focussed on the association
between serum leptin concentration and
lipid peroxidation in type 2 diabetics.
Recent studies have showed that leptin
significantly increases intracellular
reactive oxygen species in microvascular
endothelial cells, particularly in diabetics
[36]. According to our study,increased
leptin levels observed in male and female
diabetics may be related to increased lipid
peroxidation [Table/Fig 2].Literature
findings on the role of leptin in diabetes is
conflicting. Investigators have reported
either increased [37], decreased
[38],[37],[38],[39] or unchanged [40],[41]
leptin levels in diabetics. As Wauters et al.
[42] have pointed out, adiposity and
gender are the main determinants of leptin
levels in normal controls and diabetic
patients. Therefore, part of the controversy
among previous reports could be related to
the difference in the adiposity or the
gender of the patients. Many investigators
have described leptin alterations only in
obese or overweight patients [38],
[37],[40). Few workers have studied only
men [37] or women [39]. The mechanism
by which leptin stimulates oxidative stress
conditions is unclear, but it may be related
to the fact that leptin stimulates
mitochondrial fatty acid oxidation and the
increased generation of reactive radicals
[43]. Sebnem et al. [44] have observed a
significant decrease in the leptin levels in
the plasma of streptozotocin- induced
diabetic rats. Streptozotocin-induced
hypoleptinaemia may be related to a
reduced adipose tissue mass and to the
reduced assimilation and storage of energy
substrates in the fat tissue in insulin
deficiency and/or to the direct toxic effect
of streptozotocin on the adipose tissue [45].
Panarotto et al. [46] has described lower
leptin concentrations in females with
diabetes as compared to those in the
Journal of Clinical and Diagnostic Research. 2009 Dec ;(3):xx 
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control subjects. Our data only appear to
be in contrast with this finding; our
patients actually had higher leptin levels
and higher fasting serum glucose
concentrations than those studied by
Panarotto's group. Moreover, in
correlation analysis, BMI is considered to
be a significant predictor of
hyperleptinaemia [Table/Fig 2]. In the
correlation analysis using leptin as the
dependent variable, BMI and MDA were
found to be significant predictors of leptin.
In the present study, it was found that
there was a correlation between serum
leptin and BMI in males and females in
normal and diabetic subjects. Gender
specific correlation showed an association
between leptin and MDA in diabetic
patients. Serum leptin showed a significant
relationship to MDA in male and female
diabetic patients (r = 0.124 and r= 0.271, p
< 0.05). This trend reflects the increased
MDA in males and females. Therefore,
serum MDA levels are confounded by
leptin or vice versa, such that in diabetes.
Nakanishi et al. [47] have investigated the
association between leptin and oxidative
stress and have explained this association
exclusively through obesity. Many
investigators demonstrated that leptin had
a major correlation with BMI
[48,[49],[50],[51],[52]. There is still a
controversy that leptin concentrations are
affected by type 2 diabetes. Surveys of
Mexican-American [53] and German [54]
subjects showed that leptin did not differ
between normal subjects and subjects with
type 2 diabetes, with matched BMI in
males and females. In another report, it
was found that baseline plasma leptin
levels in subjects with newly diagnosed or
long-standing type 2 diabetes were not
significantly different from nondiabetic
controls matched for BMI [54]. Other
reports comparing plasma leptin levels
between controls and weight-matched
subjects with type 2 diabetes have led to
discrepant conclusions, showing no effect
[55],[56] or a decrease in leptin [57],[58].
Our present study shows a similar
relationship between leptin and oxidative
stress in obese and overweight type 2
diabetes mellitus hyperleptinaemic
patients. Finally, our study on individuals
who were referred to the Department of
Diabetes Center in 5th Azar Hospital in the
Golestan University of Medical Sciences
on the South East of the Caspian Sea
indicated that Type 2 diabetes was
associated with higher leptin and MDA
levels and BMI. In the correlation
analysis, we found a significant relation
between leptin levels and BMI in males
and females. Increased lipid peroxidation
and hyperleptinaemia may play a role in
the beginning and in the development of
type 2 diabetes mellitus.
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